NF2 and familial pancreatic carcinoma: Silencing Merlin from the MIA PaCa-2 (Supplementary Data 1B) and SUIT-2 (Figure 2A) pancreatic cancer cells significantly (p < 0.05) upregulated TOPFlash activity.